Generic Name and Formulations:
Minoxidil 2.5 mg, 10 mg; scored tabs.
Various generic manufacturers
Indications for Minoxidil:
Refractory hypertension, usually with a diuretic and β-blocker (see literature).
Initially 5 mg once daily; may increase at 3-day intervals to 10 mg/day, then 20 mg/day, then 40 mg/day (monitor closely if titrated faster). Usual range 10–40 mg/day; max 100 mg/day. If drop in diastolic pressure >30 mmHg, give in 2 divided doses.
Initially 0.2 mg/kg once daily; may increase at 3-day intervals by 50–100%. Usual range 0.25–1 mg/kg per day; max 50 mg/day.
Supervise closely. Do not use in patients with history of recurrent pericarditis, or history of recurrent or chronic pericardial effusion. Malignant hypertension. Angina. Post MI. Heart failure. Renal dysfunction. Monitor fluid and electrolyte balance, body weight, and for pericardial effusion. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid guanethidine (hospitalize until stable if used).
Pericardial effusion or tamponade, pericarditis, salt/fluid retention, cardiac failure, tachycardia, angina, hypertrichosis, rash, GI upset, ECG changes; rare: Stevens-Johnson syndrome, thromobocytopenia, leukopenia.
Formerly known under the brand names Loniten, Minodyl.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Prevalence of Major Depressive Disorder Remains High In US Population
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Evidence of Methylphenidate Abuse: Characterizing Patterns of Use in Pediatric and Adult Populations
- Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
- Most Patients Comfortable With Clinicians Asking About Sexual Orientation
- Peer-to-Peer Depression Awareness Program May Be Beneficial
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders